Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Gamble

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Heart and Vessels|January 28, 2014
Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditisTom Kai Ming Wang, Timothy Oh, Jamie Voss, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal womenAndrew Grey, Mark J Bolland, Diana Wattie, et al.
Medical Education Online|December 1, 2018
Digital devices for teaching cardiac auscultation - a randomized pilot studyMalcolm E Legget, MeiYen Toh, Andries Meintjes, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 17, 2013
Obstetric interventions for women with type 1 or type 2 diabetesTim Cundy, Joanna Morgan, Claire O'Beirne, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetateTim Cundy, Ruth Ames, Anne Horne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 14, 2013
Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trialAndrew Grey, Mark Bolland, Bobby Mihov, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MITom Km Wang, Ralph Ah Stewart, Tharumenthiran Ramanathan, et al.
BMJ Open|March 21, 2013
Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trialMark J Bolland, Alan Barber, Robert N Doughty, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 2007
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trialAndrew Grey, Mark Bolland, Greg Gamble, et al.
The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal womenRobert Young, Fiona Wu, Neil Van de Water, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Heart and Vessels|January 28, 2014
Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditisTom Kai Ming Wang, Timothy Oh, Jamie Voss, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal womenAndrew Grey, Mark J Bolland, Diana Wattie, et al.
Medical Education Online|December 1, 2018
Digital devices for teaching cardiac auscultation - a randomized pilot studyMalcolm E Legget, MeiYen Toh, Andries Meintjes, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 17, 2013
Obstetric interventions for women with type 1 or type 2 diabetesTim Cundy, Joanna Morgan, Claire O'Beirne, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetateTim Cundy, Ruth Ames, Anne Horne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 14, 2013
Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trialAndrew Grey, Mark Bolland, Bobby Mihov, et al.
European Heart Journal. Acute Cardiovascular Care|December 17, 2013
Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MITom Km Wang, Ralph Ah Stewart, Tharumenthiran Ramanathan, et al.
BMJ Open|March 21, 2013
Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trialMark J Bolland, Alan Barber, Robert N Doughty, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 2007
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trialAndrew Grey, Mark Bolland, Greg Gamble, et al.
The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal womenRobert Young, Fiona Wu, Neil Van de Water, et al.
Pageof 14